Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: Implications on virus strain selection in malignancy

International Journal of Cancer

Volumn 80, Issue 3, 1999, Pages 356-364

  Chiang, Alan K S ^a   Wong, Kai Y ^a   Liang, Anthony C T ^a   Srivastava, Gopesh ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHINESE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE DELETION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; NATURAL KILLER CELL; NOSE TUMOR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T CELL LYMPHOMA; VIRUS GENOME; VIRUS STRAIN;

ANTIGENS, VIRAL; GENE DELETION; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; NOSE; NOSE NEOPLASMS; POLYMORPHISM, GENETIC; VIRAL MATRIX PROTEINS;

EID: 0032933462     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990129)80:3<356::AID-IJC4>3.0.CO;2-D     Document Type: Article

References (27)

1. CHANG, Y.-S., SU, I.-J., CHUNG, P.-J., SHU, C.-H., NG, C.-K., WU, S.-J. and LIU, S.-T., Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int. J. Cancer, 62, 673-677 (1995).
2. CHEN, M.-L., TSAI, C.-N., LIANG, C.-L., SHU, C.-H., HUANG, C.-R., SULITZEANU, D., LIU, S.-T. and CHANG, Y.-S., Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene, 7, 2131-2140 (1992).
3. CHIANG, A.K.S., CHAN, A.C.L., SRIVASTAVA, G. and HO, F.C.S., Nasal T/NK-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int. J. Cancer, 73, 332-338 (1997).
4. CHIANG, A.K.S., TAO, Q., SRIVASTAVA, G. and HO, F.C.S., Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int. J. Cancer, 68, 285-290 (1996).
5. DE CAMPOS-LIMA, P.O., GAVIOLI, R., ZHANG, Q.-J., WALLACE, L.E., DOLCETTI, R., ROWE, M., RICKINSON, A.B. and MASUCCI, M.G., HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science, 260, 98-100 (1993).
6. DE CAMPOS-LIMA, P.O., LEVITSKY, V., BROOKS, J., LEE, S.P., HU, L.F., RICKINSON, A.B. and MASUCCI, M.G., T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. exp. Med., 179, 1297-1305 (1994).
7. HU, L.-F., CHEN, F., ZHENG, X., ERNBERG, I., CAO, S.-L., CHRISTENSSON, B., KLEIN, G. and WINBERG, G., Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene, 8, 1575-1583 (1993).
8. HU, L.-F., ZABAROVSKY, E.R., CHEN, F., CAO, S.-L., CHRISTENSSON, B., KLEIN, G. and WINBERG, G., Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J. gen. Virol., 72, 2399-2409 (1991).
9. HUEN, D.S., HENDERSON, S.A., CROOM-CARTER, D. and ROWE, M., The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene, 10, 549-560 (1995).
10. IZUMI, K.M., KAYE, K.M. and KIEFF, E.D., The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor associated factors is critical for primary B lymphocyte growth transformation. Proc. nat. Acad. Sci. (Wash.), 94, 1447-1452 (1997).
11. KHANIM, F., YAO, Q.Y., NIEDOBITEK, G., SIHOTA, S., RICKINSON, A.B. and YOUNG, L.S., Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood, 88, 3491-3501 (1996).
12. KHANNA, R., BURROWS, S.R., KURILLA, M.G., JACOB, C.A., MISKO, I.S., SCULLEY, T.B., KIEFF, E. and MOSS, D.J., Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. exp. Med., 176, 169-176 (1992).
13. KIEFF, E., Epstein-Barr virus and its replication. In: B.N. Fields, D.M. Knipe and P.M. Howley (eds.), Fields virology (3rd ed.), pp. 2343-2396, Lippincott-Raven, Philadelphia (1996).
14. KIESER, A., KILGER, E., GIRES, O., UEFFING, M., KOLCH, W. and HAMMERSCHMIDT, W., Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J., 16, 6478-6485 (1997).
15. KINGMA, D.W., WEISS, W.B., JAFFE, E.S., KUMAR, S., FREKKO, K. and RAFFELD, M., Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood, 88, 242-251 (1996).
16. KNECHT, H., BACHMANN, E., BROUSSET, P., SANDVEJ, K., NADAL, D., BACHMANN, F., ODERMATT, B.F., DELSOL, G. and PALLESEN, G., Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood, 82, 2937-2941 (1993).
17. LEUNG, S.Y., YUEN, S.T., CHUNG, L.P., CHAN, A.S.Y. and WONG, M.P., Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. Int. J. Cancer, 72, 225-230 (1997).
18. LI, S.-N., CHANG, Y.-S. and LIU, S.-T., Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene, 12, 2129-2135 (1996).
19. MILLER, W.E., EDWARDS, R.H., WALLING, D.M. and RAAB-TRAUB, N., Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. gen. Virol., 75, 2729-2740 (1994).
20. MOSIALOS, G., BIRKENBACH, M., YALAMANCHILI, R., VANARSDALE, T., WARE, C. and KIEFF, E., The Epstein-Barr virus transforming protein LMP1 engages signalling proteins for the tumor necrosis factor receptor family. Cell, 80, 389-399 (1995).
21. ROWE, M., YOUNG, L.S., CADWALLADER, K., PETTI, L., KIEFF, E. and RICKISSON, A.B., Distinction between Epstein-Barr virus type A (EBNA2A) and type B (EBNA2B) isolates extends to the EBNA3 family of nuclear proteins. J. Virol., 63, 1031-1039 (1989).
22. SAMPLE, J., YOUNG, L., MARTIN, B., CHATMAN, T., KIEFF, E., RICKINSON, A. and KIEFF, E., Epstein-Barr virus types 1 (EBV-1) and 2 (EBV-2) differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol., 64, 4084-4092 (1990).
23. SANDVEJ, K., PEH, S.-C., STORSTEIN ANDRESEN, B. and PALLESEN, G., Identification of potential hotspots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood, 84, 4053-4060 (1994).
24. TAO, Q., SRIVASTAVA, G., CHAN, A.C.L., CHUNG, L.P., LOKE, S.L. and HO, F.C.S., Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. J. med. Virol., 45, 71-77 (1995).
25. TAO, Q., SRIVASTAVA, G., DICKENS, P. and HO, F.C.S., Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps. Amer. J. Pathol. 149, 1111-1118 (1996).
26. TRIVEDI, P., HU, L.-F., CHEN, F., CHRISTENSSON, B., MASUCCI, M.G., KLEIN, G. and WINBERG, G., Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B-cell derived homologue. Europ. J. Cancer, 30A, 84-88 (1994).
27. YAO, Q.Y., TIERNEY, R.J., CROOM-CARTER, D., DUKERS, D., COOPER, G.M., ELLIS, C.J., ROWE, M. and RICKINSON, A.B., Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J. Virol., 70, 4884-4894 (1996).